SWX/GALD (SWX/GALD)

SIX Swiss Exchange: SWX/GALD · CHF

CHF 190

-1.74 (-0.9%)· Recorded snapshot

Market cap	44.2B
Revenue (ttm)	4.8B
Net income (ttm)	697.3M
EPS (ttm)	CHF 2.95
Shares out	233.2M
P/E (trailing)	64.3x
P/E (forward)	41.0x
Dividend	CHF 0.35 (0.18%)
Volume	122,976
Beta	-0.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.8B
Net income (ttm): 697.3M
EPS (ttm): CHF 2.95
P/E (trailing): 64.3x
P/E (forward): 41.0x
Market cap: 44.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E41

P25 n/aP50 n/aP75 n/a

Trailing P/E64.3

P25 n/aP50 n/aP75 n/a

ROE10.8

P25 n/aP50 n/aP75 n/a

ROIC10.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/GALD indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

USD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	Switzerland
Country code	CH
Earnings date	2027-02-25
Employees	7,676
Employees change	1,131
Employees growth	17.28%
Enterprise value	CHF 45.8B
Exchange	SIX Swiss Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1981
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CH1335392721
Last earnings date	2026-07-23
Last refreshed	2026-11-03
Market cap	CHF 44.2B
Next earnings date	2027-02-25
Price	CHF 189.75
Price currency	CHF
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	swx/GALD
Website	https://www.galderma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	50x
Average P/E ratio (3Y)	97.03x
Earnings yield	1.56%
EV/Earnings	66.22x
EV/EBIT	50.53x
EV/EBITDA	40.16x
EV/FCF	52.91x
EV/Sales	9.65x
FCF / EV yield	1.89%
FCF yield	1.95%
Forward P/E	41.04x
Graham number	43.47528
Graham upside	-76.94%
Industry P/E	60.61x
P/(FCF - SBC) ratio	54.29x
P/(OCF - SBC) ratio	48.31x
P/B ratio	6.73x
P/E ratio	64.3x
P/FCF ratio	51.17x
P/OCF ratio	45.83x
P/S ratio	9.33x
PEG ratio	1.35x
Price/EBITDA ratio	39.88x
Sector forward P/E	19.76x
Sector P/E	34.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.1%
EBITDA margin	23.4%
Effective tax rate	8.29%
FCF margin	18.04%
Gross margin	69.37%
Operating margin	19.1%
Pretax margin	15.89%
Profit margin	14.57%
Profit per employee	CHF 90,842
Profitable quarters	7
Profitable years	2
Revenue per employee	CHF 623,474
ROA	5.35%
ROCE	9.93%
ROE	10.82%
ROIC	10.28%
ROIC (5Y)	-2.15%
SBC / revenue	1.05%
Tax / revenue	1.32%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	129.78%
EPS growth (Q)	130.73%
EPS growth (QoQ)	7.21%
EPS growth quarters	7
EPS growth years	4
FCF growth	27.96%
FCF growth (Q)	1.58%
FCF growth (QoQ)	-8.51%
FCF growth 3Y	94.93%
Gross profit growth	26.59%
Gross profit growth (Q)	29.24%
Gross profit growth 3Y	19.45%
Net income growth	128.31%
Net income growth (Q)	128.87%
Net income growth (QoQ)	5.97%
Net income growth quarters	7
Net income growth years	4
OCF growth	26.81%
OCF growth (Q)	3.81%
OCF growth (QoQ)	-9.78%
OCF growth 3Y	83.34%
Operating income growth	51.41%
Operating income growth (Q)	62.92%
Operating income growth 3Y	47.91%
Revenue growth	26.29%
Revenue growth (Q)	27.66%
Revenue growth (QoQ)	13.44%
Revenue growth 3Y	19.8%
Revenue growth quarters	4
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -101.8M
Depreciation and amortization	CHF 208.2M
EBIT	CHF 913.8M
EBITDA	CHF 1.1B
EPS	CHF 2.95
FCF per share	CHF 3.74
Financing cash flow	CHF -555.1M
Free cash flow	CHF 872.6M
Free cash flow minus SBC	CHF 822.5M
Gross profit	CHF 3.3B
Income taxes	CHF 63M
Investing cash flow	CHF -117.2M
Net borrowing	CHF -175.6M
Net cash flow	CHF 307.8M
Net income	CHF 697.3M
Operating cash flow minus SBC	CHF 924.4M
Operating income	CHF 913.8M
Revenue	CHF 4.8B
Stock-based compensation	CHF 50.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.5
Book value per share	CHF 28.46
Debt / EBITDA	1.91
Debt / equity	0.33
Debt / FCF	2.51
Goodwill	CHF 4.2B
Interest coverage	7.34
Long-term assets	CHF 8.8B
Long-term liabilities	CHF 2.5B
Net cash (debt)	CHF -1.5B
Net cash / market cap	-3.4%
Net debt / EBITDA	1.35
Net debt / equity	0.23
Net debt / FCF	1.74
Piotroski F-Score	8
Property, plant and equipment	CHF 644.3M
Shareholders' equity	CHF 6.6B
Tangible book value	CHF -1.2B
Tangible book value per share	CHF -4.97
Total assets	CHF 10.9B
Total cash	CHF 677.9M
Total debt	CHF 2.2B
Total liabilities	CHF 4.3B
WACC	3.83%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.45
Current assets	CHF 2.2B
Current liabilities	CHF 1.7B
Current ratio	1.24
Inventory turnover	3.15
Net working capital	CHF -210.1M
Quick ratio	0.9
Working capital	CHF 416.9M
Working capital turnover	14.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.97%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-04-28
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	CHF 0.35
Dividend yield	0.18%
Ex-dividend date	2026-04-24
FCF payout ratio	9.35%
Last dividend	CHF 0.35
Payout ratio	12.05%
Shareholder yield	1.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CHF 168.13
1D price change	-0.91%
1M price change	17.6%
1M total return	17.6%
1W price change	2.05%
1W total return	2.05%
1Y price change	27.14%
1Y return CAGR	27.44%
1Y total return	27.42%
20-day SMA	CHF 178.53
200-day SMA	CHF 163.24
3M price change	7.43%
3M total return	7.43%
50-day SMA	CHF 168.38
50-day SMA vs 200-day SMA	50over200
52-week high	CHF 193.90
52-week high date	2026-10-26
52-week low	CHF 136.30
52-week low date	2026-03-23
6M price change	15.26%
6M total return	15.26%
All-time high	CHF 193.90
All-time high date	2026-10-26
All-time low	CHF 60.00
All-time low date	2024-03-22
Average true range (ATR)	CHF 4.72
Average volume	525.8K
Beta (1Y)	0.25
Beta (2Y)	0.58
Beta (5Y)	-0.09
Change from 52-week high	-2.14%
Change from 52-week low	39.22%
Change from all-time high	-2.63%
Change from all-time low	214.67%
Change from open	-0.34%
Day's gap	-0.57%
Dollar volume	CHF 23.3M
High price	CHF 191.00
Low price	CHF 187.30
Monthly RSI	72.79
Open price	CHF 190.40
Position in 52-week range	66.22%
Previous close	CHF 191.50
Price vs 150-day SMA	12.29%
Price vs 20-day SMA	5.75%
Price vs 200-day SMA	15.66%
Price vs 50-day SMA	12.13%
Relative volume	0.23
RSI	65.63
Sharpe ratio	0.86
Sortino ratio	1.57
Volume	123K
Weekly RSI	63.81
YTD price change	16.47%
YTD total return	16.73%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	131.3M
Shares change (QoQ)	-0.64%
Shares change (YoY)	-0.97%
Shares held by institutions	36.62%
Shares outstanding	233.2M

Deeper analysis on SWX/GALD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/GALD report

Is a complete SWX/GALD research report available?

No complete published report is available for swx/GALD (SWX/GALD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/GALD (SWX/GALD)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/GALD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/GALD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/GALD

Frequently asked questions